Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03126981 · ClinicalTrials.gov registry record · NA
Effects of Almonds on Insulin Sensitivity in Prediabetes
A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT03126981 is a NA study that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 54 participants.
The verdict
NCT03126981, a NA study, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the effects of consuming 1.5 oz almonds twice daily on insulin sensitivity and markers of cardiometabolic health in men and women with prediabetes.
Interventions
- OTHER 1.5 oz of whole, natural almonds
- OTHER Low-fat, high refined starches/sugars
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2018-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03126981
The ClinicalTrials.gov registry entry for NCT03126981 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Center for Metabolic and Cardiovascular Research, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1.5 oz of whole, natural almonds is the first listed.
NCT03126981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03126981 about?
NCT03126981 is a clinical study titled "Effects of Almonds on Insulin Sensitivity in Prediabetes". The goal of this clinical trial is to evaluate the effects of consuming 1.5 oz almonds twice daily on insulin sensitivity and markers of cardiometabolic health in men and women with prediabetes.
What is the current status of trial NCT03126981?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2017-04-20. Estimated completion is 2018-09-26.
What interventions are being tested in trial NCT03126981?
The interventions under investigation include: 1.5 oz of whole, natural almonds (OTHER), Low-fat, high refined starches/sugars (OTHER).
Who is sponsoring clinical trial NCT03126981?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.